# Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease

> **NCT00560261** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 120 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **OTHER:** NO-CO inhalation and expiration
- **OTHER:** NO-CO inhalation and expiration

## Key facts

- **NCT ID:** NCT00560261
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560261, "Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00560261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*